vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.

Shoals Technologies Group, Inc. is the larger business by last-quarter revenue ($148.3M vs $75.1M, roughly 2.0× MEDIFAST INC). On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-11.3M). Over the past eight quarters, Shoals Technologies Group, Inc.'s revenue compounded faster (27.8% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.

MED vs SHLS — Head-to-Head

Bigger by revenue
SHLS
SHLS
2.0× larger
SHLS
$148.3M
$75.1M
MED
Growing faster (revenue YoY)
SHLS
SHLS
+75.5% gap
SHLS
38.6%
-36.9%
MED
More free cash flow
MED
MED
$4.6M more FCF
MED
$-6.6M
$-11.3M
SHLS
Faster 2-yr revenue CAGR
SHLS
SHLS
Annualised
SHLS
27.8%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
SHLS
SHLS
Revenue
$75.1M
$148.3M
Net Profit
$8.1M
Gross Margin
69.4%
31.6%
Operating Margin
-10.4%
11.7%
Net Margin
5.5%
Revenue YoY
-36.9%
38.6%
Net Profit YoY
3.9%
EPS (diluted)
$-1.64
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
SHLS
SHLS
Q4 25
$75.1M
$148.3M
Q3 25
$89.4M
$135.8M
Q2 25
$105.6M
$110.8M
Q1 25
$115.7M
$80.4M
Q4 24
$119.0M
$107.0M
Q3 24
$140.2M
$102.2M
Q2 24
$168.6M
$99.2M
Q1 24
$174.7M
$90.8M
Net Profit
MED
MED
SHLS
SHLS
Q4 25
$8.1M
Q3 25
$-2.3M
$11.9M
Q2 25
$2.5M
$13.9M
Q1 25
$-772.0K
$-282.0K
Q4 24
$7.8M
Q3 24
$1.1M
$-267.0K
Q2 24
$-8.2M
$11.8M
Q1 24
$8.3M
$4.8M
Gross Margin
MED
MED
SHLS
SHLS
Q4 25
69.4%
31.6%
Q3 25
69.5%
37.0%
Q2 25
72.6%
37.2%
Q1 25
72.8%
35.0%
Q4 24
74.1%
37.6%
Q3 24
75.4%
24.8%
Q2 24
73.2%
40.3%
Q1 24
72.8%
40.2%
Operating Margin
MED
MED
SHLS
SHLS
Q4 25
-10.4%
11.7%
Q3 25
-4.6%
13.7%
Q2 25
-1.0%
14.4%
Q1 25
-1.1%
5.4%
Q4 24
0.6%
15.4%
Q3 24
1.5%
4.4%
Q2 24
-4.7%
18.7%
Q1 24
4.5%
12.8%
Net Margin
MED
MED
SHLS
SHLS
Q4 25
5.5%
Q3 25
-2.5%
8.7%
Q2 25
2.3%
12.5%
Q1 25
-0.7%
-0.4%
Q4 24
7.3%
Q3 24
0.8%
-0.3%
Q2 24
-4.8%
11.9%
Q1 24
4.8%
5.3%
EPS (diluted)
MED
MED
SHLS
SHLS
Q4 25
$-1.64
$0.05
Q3 25
$-0.21
$0.07
Q2 25
$0.22
$0.08
Q1 25
$-0.07
$0.00
Q4 24
$0.08
$0.04
Q3 24
$0.10
$0.00
Q2 24
$-0.75
$0.07
Q1 24
$0.76
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
SHLS
SHLS
Cash + ST InvestmentsLiquidity on hand
$167.3M
$7.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$600.0M
Total Assets
$248.0M
$904.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
SHLS
SHLS
Q4 25
$167.3M
$7.3M
Q3 25
$173.5M
$8.6M
Q2 25
$162.7M
$4.7M
Q1 25
$164.6M
$35.6M
Q4 24
$162.3M
$23.5M
Q3 24
$170.0M
$11.1M
Q2 24
$163.5M
$3.2M
Q1 24
$156.4M
$15.2M
Total Debt
MED
MED
SHLS
SHLS
Q4 25
Q3 25
Q2 25
Q1 25
$141.8M
Q4 24
$141.8M
Q3 24
$141.8M
Q2 24
$146.8M
Q1 24
$168.8M
Stockholders' Equity
MED
MED
SHLS
SHLS
Q4 25
$198.9M
$600.0M
Q3 25
$214.7M
$589.6M
Q2 25
$216.0M
$575.4M
Q1 25
$211.0M
$558.9M
Q4 24
$210.1M
$556.8M
Q3 24
$207.3M
$545.2M
Q2 24
$205.3M
$544.6M
Q1 24
$211.0M
$554.0M
Total Assets
MED
MED
SHLS
SHLS
Q4 25
$248.0M
$904.1M
Q3 25
$268.2M
$851.8M
Q2 25
$269.3M
$795.0M
Q1 25
$280.0M
$788.4M
Q4 24
$284.2M
$793.1M
Q3 24
$291.2M
$801.3M
Q2 24
$293.5M
$788.4M
Q1 24
$302.8M
$825.3M
Debt / Equity
MED
MED
SHLS
SHLS
Q4 25
Q3 25
Q2 25
Q1 25
0.25×
Q4 24
0.25×
Q3 24
0.26×
Q2 24
0.27×
Q1 24
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
SHLS
SHLS
Operating Cash FlowLast quarter
$-5.3M
$-4.1M
Free Cash FlowOCF − Capex
$-6.6M
$-11.3M
FCF MarginFCF / Revenue
-8.8%
-7.6%
Capex IntensityCapex / Revenue
1.8%
4.8%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
SHLS
SHLS
Q4 25
$-5.3M
$-4.1M
Q3 25
$12.1M
$19.4M
Q2 25
$-3.4M
$-13.8M
Q1 25
$3.4M
$15.6M
Q4 24
$-4.9M
$14.0M
Q3 24
$9.1M
$15.7M
Q2 24
$13.1M
$37.8M
Q1 24
$7.3M
$12.9M
Free Cash Flow
MED
MED
SHLS
SHLS
Q4 25
$-6.6M
$-11.3M
Q3 25
$10.8M
$9.0M
Q2 25
$-4.8M
$-26.0M
Q1 25
$1.9M
$12.3M
Q4 24
$-7.2M
$12.5M
Q3 24
$7.7M
$13.3M
Q2 24
$11.1M
$35.8M
Q1 24
$5.4M
$10.4M
FCF Margin
MED
MED
SHLS
SHLS
Q4 25
-8.8%
-7.6%
Q3 25
12.0%
6.6%
Q2 25
-4.5%
-23.5%
Q1 25
1.6%
15.4%
Q4 24
-6.1%
11.6%
Q3 24
5.5%
13.0%
Q2 24
6.6%
36.1%
Q1 24
3.1%
11.4%
Capex Intensity
MED
MED
SHLS
SHLS
Q4 25
1.8%
4.8%
Q3 25
1.5%
7.7%
Q2 25
1.3%
11.0%
Q1 25
1.3%
4.0%
Q4 24
1.9%
1.4%
Q3 24
1.0%
2.3%
Q2 24
1.1%
2.0%
Q1 24
1.1%
2.7%
Cash Conversion
MED
MED
SHLS
SHLS
Q4 25
-0.50×
Q3 25
1.63×
Q2 25
-1.36×
-1.00×
Q1 25
Q4 24
1.79×
Q3 24
8.04×
Q2 24
3.21×
Q1 24
0.88×
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

SHLS
SHLS

System Solutions$122.0M82%
Components$26.3M18%

Related Comparisons